Cargando…
Model-Informed Drug Development of New Cefoperazone Sodium and Sulbactam Sodium Combination (3:1): Pharmacokinetic/Pharmacodynamic Analysis and Antibacterial Efficacy Against Enterobacteriaceae
Objective: Cefoperazone/sulbactam is a commonly used antibiotic combination against the extended-spectrum beta-lactamases (ESBLs)-producing bacteria. The objective of this study was to evaluate the efficacy of a new cefoperazone/sulbactam combination (3:1) for Enterobacteriaceae infection via model-...
Autores principales: | Ji, Xi-Wei, Zhu, Xiao, Li, Yun, Xue, Feng, Kuan, Isabelle Hui San, He, Qing-Feng, Meng, Xiang-Rui, Xiang, Xiao-Qiang, Cui, Yi-Min, Zheng, Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9340253/ https://www.ncbi.nlm.nih.gov/pubmed/35924047 http://dx.doi.org/10.3389/fphar.2022.856792 |
Ejemplares similares
-
Acute localized exanthematous pustulosis caused by cefoperazone and
sodium sulbactam
por: Qu, Yan-Jing, et al.
Publicado: (2016) -
Risk-factor analysis and predictive-model development of acute kidney injury in inpatients administered cefoperazone-sulbactam sodium and mezlocillin-sulbactam sodium: a single-center retrospective study
por: Zhang, Ruiqiu, et al.
Publicado: (2023) -
Cefoperazone sodium/sulbactam sodium vs piperacillin sodium/tazobactam sodium for treatment of respiratory tract infection in elderly patients
por: Wang, Xiao-Xia, et al.
Publicado: (2021) -
Hemolytic Anemia and Reactive Thrombocytosis Associated With Cefoperazone/Sulbactam
por: Zhou, Ling, et al.
Publicado: (2019) -
Polymyxin B, Cefoperazone Sodium-Sulbactam Sodium, and Tigecycline against Multidrug-Resistant Acinetobacter baumannii Pneumonia
por: Hu, Guangxue, et al.
Publicado: (2022)